In the adolescent subgroup, 84.1% of patients treated with icotrokinra achieved IGA scores of 0/1 and 70.5% achieved PASI 90, compared with 27.3% and 13.6% receiving placebo, respectively, at week 16.

Similar to the patient in the above case, this adolescent has early-stage, favorable disease. In addition to being eligible for the aforementioned AHOD2131 trial and the OEPA and ABVD treatment ...

A 16-year-old female high school junior with a history of recurrent patellar instability presented with left knee pain following a patellar dislocation event.Two weeks earlier, she stepped onto a ...

The approval in adolescent patients was based on evidence from the phase 3 SINUS-24 and SINUS-52 trials. The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab) to ...

Credit: Getty Images Limiting screen time before bed and implementing other healthy sleep habits improves adolescent mental health, explains Dr David Thibault. Endlessly scrolling on a device late at ...

Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, ...

Natural Language Processing–Assisted Classification Models to Confirm Monoclonal Gammopathy of Undetermined Significance and Progression in Veterans' Electronic Health Records We interviewed 29 ...

Please provide your email address to receive an email when new articles are posted on . At the time of presentation, the patient was a 17-year-old male referred for evaluation of chronic right hip ...

A new survey of teen patients with cancer and their parents sheds light on a source of friction in adolescent oncology: How much access should parents have to their child’s patient portal? While ...

Friendly African American pediatrician doctor in white uniform with stethoscope talking to teen girl during visit, listening to complaint at consultation, fill patient form at medical checkup ...

Buprenorphine was associated with a 50% reduction in mortality and improved treatment retention for adolescents with opioid use disorder.